Biotechnology Research · Magdeburg
Retfit is an AI-powered clinical decision support platform that predicts individual patient response to treatment strategies for Diabetic Macular Edema (DME), enabling ophthalmologists to personalize treatment from day one. 19 million people worldwide live with DME as a result of diabetes. Today, treatment selection relies on trial and error, patients receive multiple injections before clinicians discover what works. Some never respond at all. That needs to change. Retfit analyzes what's already there; pre-treatment imaging data and delivers a clinician-ready response prediction before therapy begins. No extra scans. No new equipment. No disruption to your workflow.